DNA is the raw material of modern medicine yet is the only part of drug development not accessible at the lab bench. DNA synthesis, the first step in most biological workflows including gene synthesis ...
If someone — like a disgruntled scientist, terror group, or rogue nation — were to synthesize and unleash smallpox, we could ...
DNA, the language of biology, is driving all synthetic biology applications, from animal-free meat to life-saving therapeutics. It should come as no surprise that DNA synthesis is a hot and ...
Next-generation gene synthesis could be as transformative for several multibillion-dollar industries as the semiconductor. Over the past 60 years researchers have spent a great deal of time and money ...
SAN CARLOS, Calif.--(BUSINESS WIRE)--Elegen, the leader in next-generation DNA manufacturing, today announced the launch of ENFINIA™ Plasmid DNA, a faster, cost-effective solution for clonal synthesis ...
Demand for synthetic DNA is growing across multiple industries including cell and gene therapy development and biomanufacturing. Coupled with that growth is a need for genetic constructs that can, in ...
To our immune system, a potentially lifesaving gene therapy can look a lot like a dangerous infection. That's because most ...
The DNA synthesis start-up Camena Biosciences has closed its series A funding round with $10 million in its coffers, which it plans to use to scale its operations. The company says that the ...
8d
Ansa Biotechnologies Appoints Geoff Hamilton as Chief Financial Officer and Chief Business Officer
Experienced senior executive brings proven track record in financial strategy, operational excellence, and commercial execution ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback